Pharmaceutical Technology\'s In the Lab eNewsletter-02-06-2019

Ensuring the stability of biotherapeutics can be achieved through kinetic models that study aggregation and fragmentation.

Drug solubility can benefit from approaching solubility issues early on in the drug lifecycle.

A new reactor flask heating system now offered by Asynt allows the conduction of safe experiments in academic teaching and research labs.

Formulatrix’s FLO i8 and Flow Axial Seal Tip liquid handlers offer automated transferring.

Horizon and Rutgers University will partner to develop and commercialize new gene editing technology for therapeutic and research applications.

The company has built a fit-for-purpose liquid chromatography–mass spectrometry (LC–MS) system to streamline analytical monitoring tests for biopharmaceuticals.

The companies will embark on a multi-year research collaboration to develop in-vivo delivery modalities for CRISPR/Cas9 by leveraging ProBioGen’s existing technology and expertise.

Taconic Biosciences, a provider of genetically engineered rodent model solutions, sent mice into space to advance research on new therapies for aging-related disease processes.

Dublin, Ireland-based biopharmaceutical company Allergan will establish an R&D presence in Cambridge, MA.

Solentim and ATUM have announced a technology collaboration agreement that will focus on the creation of an efficient cell line development solution for biotherapeutic drug developers.

The company will invest $4 million to increase topical and transdermal formulation development and performance testing services at its Durham, NC, facility.